BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17199453)

  • 21. Gender, racial, and ethnic disclosure in NIH K-Award funded diabetes and obesity clinical trials.
    Guevara C; Cook C; Herback N; Pietrobon R; Jacobs DO; Vail TP
    Account Res; 2006; 13(4):311-24. PubMed ID: 17849642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of women in clinical trials of drug therapies: a context for the controversies.
    Prout MN; Fish SS
    Medscape Womens Health; 2001 Oct; 6(5):1. PubMed ID: 11698923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction.
    Rochon PA; Clark JP; Binns MA; Patel V; Gurwitz JH
    CMAJ; 1998 Aug; 159(4):321-7. PubMed ID: 9732709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. There is no women's health crisis.
    Satel SL
    Public Interest; 1998; 130():21-33. PubMed ID: 11658109
    [No Abstract]   [Full Text] [Related]  

  • 25. A Call to Action: A Systematic Review Examining the Failure to Include Females and Members of Minoritized Racial/Ethnic Groups in Clinical Trials of Pharmacological Treatments for Alcohol Use Disorder.
    Schick MR; Spillane NS; Hostetler KL
    Alcohol Clin Exp Res; 2020 Oct; 44(10):1933-1951. PubMed ID: 32997374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reporting results in U.S. clinical trials for obstructive sleep apnea and insomnia: How transparent are they?
    He Z; Wallace DM; Barnes A; Tang X; Jean-Louis G; Williams NJ
    Sleep Health; 2020 Aug; 6(4):529-533. PubMed ID: 32179065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers to racial/ethnic minority application and competition for NIH research funding.
    Shavers VL; Fagan P; Lawrence D; McCaskill-Stevens W; McDonald P; Browne D; McLinden D; Christian M; Trimble E
    J Natl Med Assoc; 2005 Aug; 97(8):1063-77. PubMed ID: 16173321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. We've come a long way, maybe: recruitment of women and analysis of results by sex in clinical research.
    Marrocco A; Stewart DE
    J Womens Health Gend Based Med; 2001 Mar; 10(2):175-9. PubMed ID: 11268300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low rate of sex-specific result reporting in cardiovascular trials.
    Blauwet LA; Hayes SN; McManus D; Redberg RF; Walsh MN
    Mayo Clin Proc; 2007 Feb; 82(2):166-70. PubMed ID: 17290722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compliance with trial registration in five core journals of clinical geriatrics: a survey of original publications on randomised controlled trials from 2008 to 2012.
    Mann E; Nguyen N; Fleischer S; Meyer G
    Age Ageing; 2014 Nov; 43(6):872-6. PubMed ID: 24982096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involving minority and underrepresented women in clinical trials: the National Centers of Excellence in Women's Health.
    Killien M; Bigby JA; Champion V; Fernandez-Repollet E; Jackson RD; Kagawa-Singer M; Kidd K; Naughton MJ; Prout M
    J Womens Health Gend Based Med; 2000 Dec; 9(10):1061-70. PubMed ID: 11153102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender bias in clinical trials: do double standards still apply?
    Ramasubbu K; Gurm H; Litaker D
    J Womens Health Gend Based Med; 2001 Oct; 10(8):757-64. PubMed ID: 11703888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. After inclusion, information and inference: reporting on clinical trials results after 15 years of monitoring inclusion of women.
    Foulkes MA
    J Womens Health (Larchmt); 2011 Jun; 20(6):829-36. PubMed ID: 21671773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status of inclusion of black participants in neuropsychological studies: A scoping review and call to action.
    Ray CGL; Hudson Mariouw K; Anderson KM; George E; Bisignano N; Hernandez S; Montgomery VL
    Clin Neuropsychol; 2022 Feb; 36(2):227-244. PubMed ID: 35001854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Federally Funded Randomized Controlled Trials Increase Analysis and Reporting of Study Outcomes by Sex, Race, and Ethnicity.
    Koch AR; Craemer KA; Garland CE; Fox WB; Jones CT; Qualls AC; Sterr JC; Geller SE
    J Womens Health (Larchmt); 2024 Jan; 33(1):14-19. PubMed ID: 37930690
    [No Abstract]   [Full Text] [Related]  

  • 36. Racial/Ethnic and Sex Representation in US-Based Clinical Trials of Hearing Loss Management in Adults: A Systematic Review.
    Pittman CA; Roura R; Price C; Lin FR; Marrone N; Nieman CL
    JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):656-662. PubMed ID: 33885733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Women's Health Initiative. Implications for practice.
    Furniss K
    Adv Nurse Pract; 2002 Nov; 10(11):53-5. PubMed ID: 12478949
    [No Abstract]   [Full Text] [Related]  

  • 38. Science by quota: P.C. medicine.
    Satel SL
    New Repub; 1995 Feb; 212(9):14, 16. PubMed ID: 11655245
    [No Abstract]   [Full Text] [Related]  

  • 39. Avoiding gender and minority barriers to NIH funding.
    Harden JT; McFarland G
    J Nurs Scholarsh; 2000; 32(1):83-6. PubMed ID: 10819743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minority recruitment and participation in health research.
    Corbie-Smith GM
    N C Med J; 2004; 65(6):385-7. PubMed ID: 15714732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.